N

Nosis Bio

Biotech firm delivering cell-targeted RNA therapeutics

In Vivo Technical Specialist

Translational Research & Bench BiologyConfirmed live in the last 24 hours
Full-timeAlameda, CA, USANo salary listedIn-person

About the Job

Requirements

  • An Associate of Science or Bachelor's degree is required.
  • At least 3 years of in vivo experience in industry or academia is required.
  • At least 1 year of experience in an industry or similar environment is required.
  • Must be able to work on site in the laboratory in Alameda, California.
  • Experience with in vivo animal studies is required.
  • Strong problem-solving skills are required.
  • Ability to collaborate across scientific disciplines is required.

Responsibilities

  • Perform in vivo pharmacokinetic/pharmacodynamic and efficacy studies in animal models, including intravenous and subcutaneous dose administration, blood sampling, tissue collection, and necropsy.
  • Adopt new techniques and develop disease models for in-house use.
  • Handle and dose animals using established protocols and ethical guidelines.
  • Collect, organize, and document experimental data accurately and maintain laboratory records in compliance with company protocols and regulatory standards.
  • Stock and maintain consumables and reagents needed for experiments.
  • Collaborate with biology, chemistry, and translational science teams to support project goals and timelines.

About the Company

Nosis Bio

Biotech firm delivering cell-targeted RNA therapeutics

Nosis Bio develops cell-targeted RNA medicines using its Connexa platform, which combines physics-informed deep learning, generative AI, and high-throughput biochemistry to design Targeted Delivery Vehicles for RNA therapies. Connexa builds a receptome atlas mapping human receptors, identifying over 2,900 cell-specific targets to allow gene silencing in precise cell types, including difficult tissues like the CNS. The company pursues a wholly owned pipeline while partnering with big pharma to apply its platform to high-value indications. Its goal is to enable safer, re-dosable RNA medicines that reach previously hard-to-target tissues, expanding treatment options for fibrosis, immune and cardiovascular diseases.

Company size
Not listed
Company stage
Not listed
Total funding
Not listed
Headquarters
Berkeley, CA
Founded
2021

Recently Posted Jobs

Explore more opportunities at Nosis Bio

See more jobs